Psychological Distress and Coping Strategies in Breast Cancer Patients Under Neoadjuvant Therapy: A Systematic Review

Overview

Journal Womens Health (Lond)

Specialty Gynecology & Obstetrics

Date 2024 Sep 17

PMID 39287572

Authors

Majid Omari

Lamiae Amaadour

Achraf El Asri

Zineb Benbrahim

Nawfel Mellas

Karima El Rhazi

Mohammed El Amine Ragala

Jaouad El Hilaly

Karima Halim

Btissame Zarrouq

Affiliations

Soon will be listed here.

Abstract

Background: During neoadjuvant therapy (NAT), patients with locally advanced breast cancer (LABC) experience psychological distress (PD) and adopt appropriate coping strategies.

Objective: This systematic review aimed to examine the prevalence and changes in PD and coping strategies in patients with LABC during NAT and to evaluate effective interventions to reduce their PD.

Design: Quantitative (cross-sectional, longitudinal, and interventional) and qualitative studies reporting PD and coping strategies related to NAT during LABC were included.

Data Sources And Methods: PubMed, Cochrane Library, Scopus, ScienceDirect, Wiley Online Library, and Web of Science databases were consulted to gather relevant literature from the first publications until July 25, 2023. Selection was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Results: A total of 41 articles were included, of which four were qualitative. The main results showed that the prevalence of depression before NAT ranged from 0% to 46% and that of anxiety from 5.5% to 54%. After NAT, the prevalence of depression ranged from 40% to 78.5% and anxiety accounted for 27%. Additionally, PD decreased during NAT. The main determinants of PD were perceived social support, living in joint families, being affected by COVID-19 infection, delays in diagnosis, and starting neoadjuvant treatment. For coping strategies, after NAT, "resigned coping" decreased, whereas "social support" increased, and active coping strategies were correlated with better PD. Some interventions found a reduction in PD, such as a mobile health application, fasting-mimicking diet, relaxation training, and guided imaging.

Conclusion: These findings highlight the importance of considering PD and coping strategies in patients with LABC from diagnosis to the end of NAT. The results suggest that effective psychological interventions should be implemented.

References

Zhou X, Tan Y, Yu H, Liu J, Lan X, Deng Y . Early alterations in cortical morphology after neoadjuvant chemotherapy in breast cancer patients: A longitudinal magnetic resonance imaging study. Hum Brain Mapp. 2022; 43(15):4513-4528. PMC: 9491291. DOI: 10.1002/hbm.25969. View

Rodriguez-Gonzalez A, Hernandez R, Cruz-Castellanos P, Fernandez-Montes A, Castillo-Trujillo O, Munoz M . Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer. Health Qual Life Outcomes. 2023; 21(1):15. PMC: 9936733. DOI: 10.1186/s12955-023-02099-w. View

Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R . Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol. 2013; 24(9):2278-84. DOI: 10.1093/annonc/mdt182. View

Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A . Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353(9159):1119-26. DOI: 10.1016/s0140-6736(99)02143-1. View

Lugtenberg R, de Groot S, Kaptein A, Fischer M, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M . Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial. Breast Cancer Res Treat. 2020; 185(3):741-758. PMC: 7921018. DOI: 10.1007/s10549-020-05991-x. View

Al-Azri M, Al-Awisi H, Al-MoundhrI M . Coping with a diagnosis of breast cancer-literature review and implications for developing countries. Breast J. 2009; 15(6):615-22. DOI: 10.1111/j.1524-4741.2009.00812.x. View

Zhao Y, Chen L, Zheng X, Shi Y . Quality of life in patients with breast cancer with neoadjuvant chemotherapy: a systematic review. BMJ Open. 2022; 12(11):e061967. PMC: 9677026. DOI: 10.1136/bmjopen-2022-061967. View

Barakat H, Hussein R, Elberry A, Zaki M, Ramadan M . The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial. Sci Rep. 2022; 12(1):7656. PMC: 9091204. DOI: 10.1038/s41598-022-11138-3. View

Walker L, Walker M, Ogston K, Heys S, Ah-See A, Miller I . Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer. 1999; 80(1-2):262-8. PMC: 2363003. DOI: 10.1038/sj.bjc.6690349. View

10.

Lee S, Jung S, Jung S, Moon J, Oh G, Yeom C . Psychiatric symptoms mediate the effect of resilience on health-related quality of life in patients with breast cancer: Longitudinal examination. Psychooncology. 2021; 31(3):470-477. DOI: 10.1002/pon.5829. View

11.

Basen-Engquist K, Raber M, Carmack C, Arun B, Brewster A, Fingeret M . Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study. Support Care Cancer. 2020; 28(12):5821-5832. PMC: 8926393. DOI: 10.1007/s00520-020-05411-2. View

12.

Yao C, Rich J, Tannock I, Seruga B, Tirona K, Bernstein L . Pretreatment Differences in Intraindividual Variability in Reaction Time between Women Diagnosed with Breast Cancer and Healthy Controls. J Int Neuropsychol Soc. 2016; 22(5):530-9. DOI: 10.1017/S1355617716000126. View

13.

Andersen B, Lacchetti C, Ashing K, Berek J, Berman B, Bolte S . Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. J Clin Oncol. 2023; 41(18):3426-3453. DOI: 10.1200/JCO.23.00293. View

14.

Lim C, Devi M, Ang E . Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011; 9(3):215-35. DOI: 10.1111/j.1744-1609.2011.00221.x. View

15.

Donovan-Kicken E, Caughlin J . Breast cancer patients' topic avoidance and psychological distress: the mediating role of coping. J Health Psychol. 2011; 16(4):596-606. DOI: 10.1177/1359105310383605. View

16.

Chintamani , Gogne A, Khandelwal R, Tandon M, Jain S, Kumar Y . The correlation of anxiety and depression levels with response to neoadjuvant chemotherapy in patients with breast cancer. JRSM Short Rep. 2011; 2(3):15. PMC: 3086323. DOI: 10.1258/shorts.2010.010072. View

17.

Gundelach A, Henry B . Cancer-Related Psychological Distress: A Concept Analysis. Clin J Oncol Nurs. 2016; 20(6):630-634. DOI: 10.1188/16.CJON.630-634. View

18.

Cook S, Salmon P, Hayes G, Byrne A, Fisher P . Predictors of emotional distress a year or more after diagnosis of cancer: A systematic review of the literature. Psychooncology. 2018; 27(3):791-801. PMC: 5873392. DOI: 10.1002/pon.4601. View

19.

Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi S, Balouchi A . Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019; 176(3):519-533. DOI: 10.1007/s10549-019-05271-3. View

20.

Dunkel-Schetter C, Feinstein L, Taylor S, Falke R . Patterns of coping with cancer. Health Psychol. 1992; 11(2):79-87. DOI: 10.1037//0278-6133.11.2.79. View